51S Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cynata Therapeutics Ltd

Watchlist Manager

Watchlist

Price: 0.006 EUR -14.29% Market Closed

Market Cap: €1.1m

	Cynata Therapeutics Ltd F:51S	AU
	Aneka Tambang Tbk PT F:AKTA	ID
T	Timberwell Bhd KLSE:TIMWELL	MY
	Sulzer AG SIX:SUN	CH
N	NL Development PCL SET:NL	TH

Profitability Summary

Cynata Therapeutics Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-9 730%

Negative 3Y Average Operating Margin

-4 465%

Declining Operating Margin

-4 119% > -9 730%

Negative Net Margin

-11 433%

Negative 3Y Average Net Margin

-4 733%

Declining Net Margin

-4 046% > -11 433%

Negative Free Cash Flow Margin

-8 473%

Negative 3Y Average Free Cash Flow Margin

-4 069%

Declining Free Cash Flow Margin

-4 047% > -8 473%

Negative ROE

-325%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-762%

Declining ROIC

-1 103% > -1 299%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.